Thought leader perspectives on benefits and harms in precision medicine research
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Precision medicine research is underway to identify targeted approaches to improving health and preventing disease. However, such endeavors raise significant privacy and confidentiality concerns. The objective of this study was to elucidate the potential benefits and harms associated with precision medicine research through in-depth interviews with a diverse group of thought leaders, including primarily U.S.-based experts and scholars in the areas of ethics, genome research, health law, historically-disadvantaged populations, informatics, and participant-centric perspectives, as well as government officials and human subjects protections leaders. The results suggest the prospect of an array of individual and societal benefits, as well as physical, dignitary, group, economic, psychological, and legal harms. Relative to the way risks and harms are commonly described in consent forms for precision medicine research, the thought leaders we interviewed arguably emphasized a somewhat different set of issues. The return of individual research results, harm to socially-identifiable groups, the value-dependent nature of many benefits and harms, and the risks to the research enterprise itself emerged as important cross-cutting themes. Our findings highlight specific challenges that warrant concentrated care during the design, conduct, dissemination, and translation of precision medicine research and in the development of consent materials and processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“But genetic information also opens up the possibility of stigmatization of certain groups [57].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [57]
The cited source says what the claim attributes to it.
In the citing paper
“Apart from these positive assessments, studies also demonstrate that some professionals are uncertain about the value of genetic testing [51, 90] and doubt that all patients will benefit significantly from PM [30, 31, 42, 49, 54, 57].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability
Guest, G., Bunce, A., & Johnson, L. (2006) · Field Methods · doi:10.1177/1525822x05279903 · Cited by 20,808 · cited 1×
“We used stratified purposive sampling to interview at least six thought leaders per group, the minimum expected to reach saturation [7].”
MethodBasics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory
Corbin, J., & Strauss, A. (2008) · SAGE · doi:10.4135/9781452230153 · Cited by 12,136 · cited 1×
“We uploaded transcribed interviews into qualitative research software, NVivo 11, and used an overarching grounded theory approach and constant comparison to code and analyze the data [9, 10].”
Guest, G., MacQueen, K., & Namey, E. (2012) · doi:10.4135/9781483384436 · Cited by 7,924 · cited 1×
“Once all data were coded, the team systematically generated narrative summaries of relevant structural and content codes to explore the range of thematic responses and to identify additional sub-themes [11, 12].”
Method(2008) · Cited by 7,674
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
A Purposeful Approach to the Constant Comparative Method in the Analysis of Qualitative Interviews
Boeije, H. (2002) · Quality and Quantity · doi:10.1023/a:1020909529486 · Cited by 3,073 · cited 1×
“We uploaded transcribed interviews into qualitative research software, NVivo 11, and used an overarching grounded theory approach and constant comparison to code and analyze the data [9, 10].”
MethodAnalyzing Qualitative Data: Systematic Approaches
Bernard, H. R., & Ryan, G. W. (2009) · Cited by 2,373
AACR Project GENIE: Powering Precision Medicine through an International Consortium
The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0151 · Cited by 1,964 · cited 1×
“and around the world to accelerate progress on precision medicine, including the use of genomic, environmental, and lifestyle information to identify new and more targeted ways to improve the diagnosis, treatment, and prevention of disease [1, 2].”
BackgroundWolf, S. M., Crock, B. N., Van Ness, B., Lawrenz, F., Kahn, J. P., Beskow, L. M., Cho, M. K., Christman, M. F., Green, R. C., Hall, R., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.23 · Cited by 436
Self-citationJarvik, G. P., Amendola, L. M., Berg, J. S., Brothers, K., Clayton, E. W., Chung, W., Evans, B. J., Evans, J. P., Fullerton, S. M., Gallego, C. J., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.04.009 · Cited by 369
Cited by
Erdmann, A., Rehmann-Sutter, C., & Bozzaro, C. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00682-8 · Cited by 86
“Apart from these positive assessments, studies also demonstrate that some professionals are uncertain about the value of genetic testing [51, 90] and doubt that all patients will benefit significantly from PM [30, 31, 42, 49, 54, 57].”
BackgroundInfluentialThought Leader Perspectives on Participant Protections in Precision Medicine Research
Hammack, C. M., Brelsford, K. M., & Beskow, L. M. (2019) · Journal of Law, Medicine & Ethics · doi:10.1177/1073110519840493 · Cited by 21
Self-citationCurrent ethical and social issues in epidemiology
Salerno, J., Coughlin, S. S., Goodman, K. W., & Hlaing, W. M. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.02.001 · Cited by 23
Wolf, L. E., Hammack‐Aviran, C. M., Brown, E. C. F., Brelsford, K. M., & Beskow, L. M. (2020) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110520917000 · Cited by 17
Self-citationDo Groups Have Moral Standing in Unregulated mHealth Research?
Yu, J., & Juengst, E. T. (2020) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110520917037 · Cited by 12
Metadata
- Authors
- Beskow, L. M., Hammack, C. M., & Brelsford, K. M.
- Affiliations
- Vanderbilt University Medical Center (US)
- Corresponding author
- Beskow, Laura M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-26
- Volume
- 13
- Issue
- 11
- Pages
- e0207842
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6258115
- OpenAlex
- W2902603209
- Cited by
- 22
- References
- 47
- Citations by year
- 2024: 7 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 6 · 2019: 2
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Human Genome Research Institute (R01-HG-007733)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- research ethics, benefits and harms, informed consent, genomic research, privacy and confidentiality, research participant protection
- MeSH terms
- Stakeholder Participation, Confidentiality, Cost-Benefit Analysis, Expert Testimony, Humans, Insurance, Health, Interviews as Topic, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thought leader perspectives on benefits and harms in precision medicine research. https://app.cochat.ai/papers/10.1371/journal.pone.0207842
- The paper
- Beskow, L. M., Hammack, C. M., & Brelsford, K. M. (2018). Thought leader perspectives on benefits and harms in precision medicine research. PLOS ONE. https://doi.org/10.1371/journal.pone.0207842
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.